Search

Your search keyword '"Yi‐Ling Hu"' showing total 88 results

Search Constraints

Start Over You searched for: Author "Yi‐Ling Hu" Remove constraint Author: "Yi‐Ling Hu"
88 results on '"Yi‐Ling Hu"'

Search Results

1. Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins

2. Detecting Prefrailty: Comparing Subjective Frailty Assessment and the Paulson–Lichtenberg Frailty Index

3. Protocol for the home hazards removal program (HARP) study: a pragmatic, randomized clinical trial and implementation study

4. Building Streptomyces albus as a chassis for synthesis of bacterial terpenoids

5. The Social Cost of Providing Care to Older Adults With and Without Dementia

7. Preventing Falls by Integrating Functional Exercise into Habitual Daily Routines

9. Resistance and phylogeny guided discovery reveals structural novelty of tetracycline antibiotics

11. Discovery and biosynthesis of guanipiperazine from a NRPS-like pathway

12. Habit Formation Intervention to Reduce Frailty Risk Factors: A Feasibility Study

13. Biosynthesis of Sordarin Revealing a Diels-Alderase for the Formation of the Norbornene Skeleton

14. Associations between Affiliate Stigma and Quality of Life among Caregivers of Individuals with Dementia: Mediated Roles of Caregiving Burden and Psychological Distress.

15. Evaluation of race as a predictor of fear of falling in Black older adults

16. Fall Prevention Bingo: Effects of a Novel Community-based Education Tool on Older Adults Knowledge and Readiness to Reduce Risks for Falls

17. Feasibility of an Automated Bidet Intervention to Decrease Caregiver Burden

18. Direct-Bandgap Bilayer WSe

19. Home Hazard Removal to Reduce Falls Among Community-Dwelling Older Adults

20. Feasibility of a Habit Formation Intervention to Delay Frailty Progression Among Older African Americans: A Pilot Study

23. Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins

24. Feasibility of a novel intervention to improve participation after stroke

25. Protocol for the home hazards removal program (HARP) study: a pragmatic, randomized clinical trial and implementation study

26. A scoping review of fall hazards in the homes of older adults and development of a framework for assessment and intervention

27. Translating a Functional Exercise Program for Fall Prevention Among Diverse Older Adults in Urban Medically Underserved Areas: A Mixed Methods Study

28. Intervention to Modify Habits: A Scoping Review

29. Associated factors with parental pregnancy decision-making and use of consultation after a prenatal congenital heart disease diagnosis

30. Predictors of Engagement in Home Activities Among Community-Dwelling Older Adults

31. Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)

32. Acceptability and Feasibility of ActivPAL Activity Tracker for Pre-Frail African American Older Adults

33. Evaluation of Race as a Predictor of Fear of Falling in Black Older Adults

35. DETECTING PRE-FRAILTY STATUS: COMPARISON OF CLINICAL JUDGMENTS AND THE PAULSON LICHTENBERG FRAILTY INDEX

36. Fetal arrhythmias case series: Experiences from a fetal screening center in Taiwan

37. Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease

38. Scoring, Clinical Utility, and Psychometric Properties of the In-Home Medication Management Performance Evaluation (HOME–Rx)

39. Development and Evaluation of Novel Phosphotyrosine Mimetic Inhibitors Targeting the Src Homology 2 Domain of Signaling Lymphocytic Activation Molecule (SLAM) Associated Protein

40. Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)

41. Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors

42. RETENTION OF PARTICIPANTS IN LONGITUDINAL ALZHEIMER’S DISEASE STUDIES: WHO STAYS?

43. HOME HAZARD REMOVAL TO REDUCE THE RATE OF FALLS AMONG COMMUNITY DWELLING OLDER ADULTS: A RANDOMIZED CLINICAL TRIAL

44. Radiated seismic energy from the 2021 ML 5.8 and ML 6.2 Shoufeng (Hualien), Taiwan, earthquakes and their aftershocks

45. Development of activity-based probes with tunable specificity for protein tyrosine phosphatase subfamilies

46. 1-(2-((Z)-6-(2-(Trifluoromethyl)phenyl)hexa-3-en-1,5-diynyl)phenyl)piperidin-2-one as a new potent apoptosis agent

47. Expression of Long-Term Plasticity at Individual Synapses in Hippocampus Is Graded, Bidirectional, and Mainly Presynaptic: Optical Quantal Analysis

48. Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors

49. Feasibility Trial of Tailored Home Modifications: Process Outcomes

50. In-Home Medication Management Performance Evaluation (HOME–Rx): A Validity Study

Catalog

Books, media, physical & digital resources